Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD boosted its holdings in Nova Ltd. (NASDAQ:NVMI - Free Report) by 123.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 67,973 shares of the semiconductor company's stock after acquiring an additional 37,535 shares during the period. Nova accounts for about 1.4% of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD's portfolio, making the stock its 26th largest holding. Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD owned approximately 0.23% of Nova worth $18,717,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ASR Vermogensbeheer N.V. purchased a new stake in Nova in the first quarter valued at approximately $26,000. Parallel Advisors LLC increased its holdings in Nova by 182.7% in the second quarter. Parallel Advisors LLC now owns 212 shares of the semiconductor company's stock valued at $58,000 after buying an additional 137 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in Nova by 51.6% in the first quarter. Advisors Asset Management Inc. now owns 376 shares of the semiconductor company's stock valued at $69,000 after acquiring an additional 128 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Nova by 13.8% in the second quarter. Farther Finance Advisors LLC now owns 306 shares of the semiconductor company's stock valued at $84,000 after acquiring an additional 37 shares in the last quarter. Finally, Flaharty Asset Management LLC acquired a new position in Nova in the first quarter valued at $92,000. Hedge funds and other institutional investors own 82.99% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Nova in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $282.50.
Get Our Latest Analysis on Nova
Nova Stock Performance
Nova stock opened at $340.35 on Friday. The firm has a market cap of $10.01 billion, a PE ratio of 46.31, a P/E/G ratio of 2.27 and a beta of 1.76. The firm's 50 day moving average price is $294.51 and its two-hundred day moving average price is $251.30. Nova Ltd. has a twelve month low of $153.99 and a twelve month high of $342.00.
Nova (NASDAQ:NVMI - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The semiconductor company reported $2.20 earnings per share for the quarter, beating analysts' consensus estimates of $2.05 by $0.15. Nova had a net margin of 29.10% and a return on equity of 24.36%. The firm had revenue of $219.99 million during the quarter, compared to the consensus estimate of $214.95 million. During the same period in the prior year, the firm earned $1.61 EPS. The business's revenue was up 40.2% on a year-over-year basis. Nova has set its Q3 2025 guidance at 2.020-2.220 EPS. Equities analysts anticipate that Nova Ltd. will post 7.52 EPS for the current fiscal year.
About Nova
(
Free Report)
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nova wasn't on the list.
While Nova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.